All updates
All updates
today 49中文产业新闻精选Chinese source评分6060
顶刊论文（社媒热度）精选评分6363 Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.
NEJM评分00 Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
文献与产业新闻精选评分5454 STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial
文献与产业新闻精选评分4141 Hydrogen-rich water combined with traditional Chinese medicine compound in the treatment of kidney stones: a randomized controlled prospective clinical trial
medRxiv Oncology评分2222 The ''Hamburg Life After Cancer Program'': Development, Implementation and Evaluation of a Structured Survivorship Program - Study Protocol of a Hybrid Effectiveness-Implementation Study
The Lancet精选评分5252 [Articles] Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial
文献与产业新闻精选评分5454 Merck, Gilead’s failed Trodelvy lung cancer trial shows better China results
文献与产业新闻精选评分4444 Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win
文献与产业新闻精选评分4444 Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
中文产业新闻精选Chinese source评分6767 礼来Foundayo两项ATTAIN三期临床证据拆解：72周最高减重12.4%，覆盖糖尿病与非糖尿病人群
中文产业新闻精选Chinese source评分6969 Arrowhead 吸入式 siRNA ARO-RAGE 人体试验显示肺部 RAGE 剂量依赖性沉默
顶刊论文（社媒热度）精选评分6969 Loberamisal for Acute Ischemic Stroke: The LAIS Randomized Clinical Trial.
顶刊论文（社媒热度）精选评分6767 Complete Regression of Hepatoblastoma after Interleukin-15- and Interleukin-21-Coexpressing CAR T-Cell Therapy.
文献与产业新闻精选评分4848 BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readout
文献与产业新闻精选评分5353 GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
文献与产业新闻精选评分5151 Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Cell精选评分4242 Glycocalyx-edited mesenchymal stem/stromal cell therapy in advanced osteoporosis
文献与产业新闻精选评分5151 Novartis DM1 miss raises stakes for next wave of DMPK readouts
顶刊论文（社媒热度）评分4545 Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence: The ADHERE-ASCVD Randomized Clinical Trial.
文献与产业新闻评分3535 AbbVie lines up Qulipta expansion with phase 3 win in untapped menstrual migraine indication
顶刊论文（社媒热度）精选评分5656 Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.
文献与产业新闻评分1414 Author Correction: Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial
文献与产业新闻精选评分7070 Akeso, Summit’s ivonescimab tops Keytruda in lung cancer survival, with strong data in PD-L1-high patients
中文产业新闻精选Chinese source评分6060 阿斯利康Tozorakimab两项Ⅲ期试验在慢阻肺病急性加重上显示显著改善
文献与产业新闻评分2828 BioMarin pads case for Voxzogo expansion as achondroplasia competition field shifts
文献与产业新闻评分2626 Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock
NEJM精选评分6060 Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
文献与产业新闻评分3535 Beeline flies into phase 3 as oral lupus drug soars past placebo
文献与产业新闻评分3535 Evommune gives up hope for MRGPRX2 antagonist to treat itch after latest phase 2 fail
文献与产业新闻精选评分4545 Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
文献与产业新闻精选评分4747 Sintilimab‑related cystitis/ureteritis in high‑grade endometrial stromal sarcoma: A case report and structured literature review
文献与产业新闻精选评分4444 Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial
文献与产业新闻精选评分5656 The factors that could have contributed to Novartis’ Lp(a) miss
文献与产业新闻评分1919 Novartis’ Phase III misses, pharma deals analysis, MFN carve-outs — a BioCentury podcast
文献与产业新闻评分2525 Novartis’ Phase III misses compound Novo’s cardiovascular setback
文献与产业新闻评分2222 STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
中文产业新闻精选Chinese source评分7272 正序生物碱基编辑疗法在不同遗传背景β-血红蛋白病患者中实现临床治愈